In Collaboration With

Endpoints is the biopharma and healthcare industries' trusted source for up-to-the-moment news, in-depth reporting on science and business, and coverage of the people, companies and money that drive innovation.

Strategic Partner

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being the recipient of the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships and named “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. 

View their privacy policy here.

Global Knowledge Partner

McKinsey & Company is a global management consulting firm committed to helping organizations accelerate sustainable and inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.

View their privacy policy here.

Associate Partner

AtaiBeckley is a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments. AtaiBeckley’s pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder. The Company is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. These programs aim to create breakthroughs in mental health through transformative interventional psychiatry therapies that can integrate seamlessly into healthcare systems.  

View their privacy policy here.

Associate Sponsor

Forvis Mazars is a leading global professional services firm specialising in audit, tax, advisory and consulting. With over 40,000 professionals across 100+ countries and territories, we combine international scale with local expertise to deliver tailored solutions. Our dedicated Life Sciences and Pharma team, with specialist hubs in the UK, USA, Switzerland, France, Germany and Ireland, empowers clients to navigate regulatory complexity, drive innovation and achieve sustainable growth. Whether supporting biotech pioneers or global pharmaceutical leaders, we are committed to providing an unmatched client experience, one that feels right, personal and natural to each and every one of our clients.

View their privacy policy here.

We have a few packages remaining, get in touch today to see how you can get involved.